| The product name | 尼洛替尼 | Report progress | Prepare to register |
| English names | Nilotinib | indications | Treatment of various leukemias, including chronic myeloid leukemia (CML) |
| CAS no. | 641571-10-0 | place of origin | |
| IDL no./Registration no. | Dosage form | API | |
| Chemical name | 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide | ||
粤公安网备44010402000131